NEXT

Delaware Business Court Insider

Del. Supreme Court Upholds Dismissal in AbbVie Inversion Case

A three-judge panel of the high court Monday upheld, by order, a Chancery Court decision from July that dismissed the suit on demand futility grounds, finding that the directors did not face a substantial risk of liability for their role in scuttling the $55 million deal.
4 minute read

The Legal Intelligencer

Generic Drug Antitrust Litigation Clears Standing Hurdle

The defendants, which consist of 25 pharmaceutical companies, had argued that plaintiffs did not have standing to bring claims based on state laws in jurisdictions where the class representatives did not either purchase or resell the drugs at issue.
3 minute read

New Jersey Law Journal

After Pfizer Ruling, Here Are Keys to Using Electronic Media to Present Binding Arbitration Policies

The "Skuse" appeals court said the manner of presenting the arbitration clause was too "oblique" and failed to provide the requisite assent of employees.
7 minute read

The Legal Intelligencer

PPI Litigation—Why These Lawsuits Are Like No Other

In most mass tort cases there is a distinct injury or injuries established from the onset of litigation; however, this is not the case with the Proton Pump Inhibitor (PPI) lawsuits.
6 minute read

Litigation Daily

Daily Dicta: Wilmer, Latham Lawyers Swatted in Red-Hot Discovery Fight over World's Best-Selling Drug

A fed-up magistrate judge in Delaware ordered pharma giant AbbVie to turn over requested discovery materials to Boehringer Ingelheim in a patent fight over Humira, the world's best-selling drug.
7 minute read

Delaware Business Court Insider

AbbVie Ordered to Quickly Produce Docs in Humira Infringement Suit

The Feb. 8 ruling, from U.S. Magistrate Judge Richard A. Lloret, came in response to Boehringer's second set of production requests pertaining to its "unclean hands" defense in Abbvie's infringement suit, which accuses the German drugmaker of trying to illegally capitalize on Humira's clinical success.
4 minute read

New Jersey Law Journal

Bayer Wins $155M Patent Infringement Verdict Over Hemophilia Treatment

A federal jury has ordered a unit of Takeda Pharmaceutical Co. to pay Bayer HealthCare LLC $155 million in damages for infringing a patent related to Bayer's hemophilia treatment.
3 minute read

Litigation Daily

Litigators of the Week: Latham's Lethal IP Litigators Kill Patent Challenge to $2B-a-Year Drug

Latham & Watkins global IP co-chair Michael Morin and partner David Frazier delivered a save worth billions to clients Janssen Biotech Inc. and Genmab A/S.
11 minute read

Corporate Counsel

After 18 Years at LabCorp, Deputy Chief Legal Officer Appointed Global General Counsel

LabCorp chief legal officer F. Samuel Eberts III is retiring after 15 years in the role. Sandy van der Vaart, who has held a number of leadership roles in the lab testing company's legal department over the last 18 years, will become LabCorp's new top lawyer.
3 minute read

The Legal Intelligencer

Woman Who Needed 9 Surgeries to Fix Defective Mesh Awarded $41M

A Philadelphia jury has awarded $41 million to a woman who underwent nine surgeries to treat injuries she allegedly sustained as a result of defective transvaginal mesh.
4 minute read

Resources

  • The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025

    Brought to you by Erase.com

    Download Now

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now